Defence stocks fire up! Paras Defence, GRSE, other stocks jump up to 10% as govt notifies 6th indigenisation list
Defence stocks surged up to 10% after the Defence Ministry unveiled its sixth Positive Indigenisation List covering 405 items with Rs 3,070 crore business potential. The move aims to boost domestic manufacturing, innovation and investment while reducing India’s dependence on defence imports.
Nifty to hit 50,000 before 2035? Raamdeo Agrawal maps 3 valuation-based timelines
The Nifty 50 index might soar to 50,000 in the next six to nine years. This forecast hinges on the fluctuations of price-to-earnings ratios. A surge in retail participation and robust domestic investments is solidifying market resilience, even as foreign institutional investors scale back their stakes in Indian equities. The nation’s economic growth and rising […]
Regulatory tailwinds to boost growth for MCX, says HDFC Securities; retains Buy for 18% gains
HDFC Securities retained its Buy rating on MCX with a Rs 3,600 target, citing regulatory easing, FPI participation and new bullion and metals index options. The brokerage expects these changes to boost options premiums, volumes and earnings while improving capital efficiency.
Colgate-Palmolive shares fall over 2% after Investor Day. What Goldman Sachs and other brokerages are saying
Colgate-Palmolive shares slipped after the company’s Investor Day 2026, as investors weighed higher brand investments against its long-term growth and profitability strategy. While Goldman Sachs retained a Neutral view, Motilal Oswal and Nuvama maintained Buy ratings, citing volume recovery, premiumisation and category expansion as key growth drivers.
Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjector
Biocon shares rose after its US subsidiary received supplemental FDA approval for Yesintek single-dose prefilled autoinjectors in two strengths. The approval expands Biocon’s US immunology portfolio, with Yesintek used to treat conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
Welspun Living shares surge 8%; stock gains 14% in 3 days. What’s driving the rally?
Welspun Living shares surged nearly 8% on Tuesday, extending gains to nearly 14% over three sessions after the company reported a strong Q1FY27 performance. Brokerages Motilal Oswal and JM Financial retained their Buy ratings, citing improving fundamentals, margin expansion and further earnings growth potential.
Tube Investments of India shares surge 8% after Q1 earnings. What Motilal Oswal is saying
Tube Investments of India shares surged after the company reported a 5% year-on-year decline in Q1FY27 profit to Rs 158.62 crore, despite a 17.7% rise in revenue to Rs 2,227.63 crore. Motilal Oswal retained its Buy rating with a Rs 3,379 target, citing strong core business performance, 17% engineering volume growth and double-digit export growth.
Hindustan Copper, Vedanta, other metal stocks slip up to 2% after sharp gains. Should you buy the dip or avoid?
Metal stocks came under pressure after a sharp rally in the previous session, as global metal prices corrected amid concerns over China’s economic data and geopolitical developments. Analysts, however, see selective opportunities in the sector, with Hindustan Copper and Nalco among the stocks highlighted.
Mukul Agrawal-backed PTC Industries shares slip 4% despite 466% surge in Q1 profit and 180% EBITDA growth
PTC Industries shares fell 4% despite a strong Q1 FY27 performance, with profit surging 466% and EBITDA rising 180%. Revenue grew 83% year-on-year to ₹197.1 crore, supported by aerospace and defence programmes. Investors Mukul Agrawal and Vikas Khemani held 1.07% and 2.57% stakes, respectively, as of June 2026.
Sigma Advanced Systems shares rally 5% on Rs 155 crore anti-drone orders; stock up 105% in 3 months
Sigma Advanced Systems shares gained nearly 5% after the defence technology company announced orders worth around Rs 155 crore for its Indrajaal Ranger anti-drone system. The stock has surged 105% in three months, while its order book stands at approximately Rs 8,000 crore, supporting strong revenue visibility.